Repare Therapeutics (RPTX) Competitors $2.84 -0.04 (-1.39%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RPTX vs. BDTX, MREO, ARCT, ALMS, YMAB, ZVRA, ESPR, RGNX, SLRN, and MGTXShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Black Diamond Therapeutics (BDTX), Mereo BioPharma Group (MREO), Arcturus Therapeutics (ARCT), Alumis (ALMS), Y-mAbs Therapeutics (YMAB), Zevra Therapeutics (ZVRA), Esperion Therapeutics (ESPR), REGENXBIO (RGNX), Acelyrin (SLRN), and MeiraGTx (MGTX). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. Black Diamond Therapeutics Mereo BioPharma Group Arcturus Therapeutics Alumis Y-mAbs Therapeutics Zevra Therapeutics Esperion Therapeutics REGENXBIO Acelyrin MeiraGTx Black Diamond Therapeutics (NASDAQ:BDTX) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, community ranking, media sentiment, valuation and risk. Do analysts rate BDTX or RPTX? Black Diamond Therapeutics presently has a consensus price target of $15.50, indicating a potential upside of 537.86%. Repare Therapeutics has a consensus price target of $10.00, indicating a potential upside of 252.11%. Given Black Diamond Therapeutics' higher possible upside, equities research analysts clearly believe Black Diamond Therapeutics is more favorable than Repare Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Black Diamond Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Repare Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is BDTX or RPTX more profitable? Black Diamond Therapeutics has a net margin of 0.00% compared to Repare Therapeutics' net margin of -99.76%. Repare Therapeutics' return on equity of -40.87% beat Black Diamond Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Black Diamond TherapeuticsN/A -68.08% -49.65% Repare Therapeutics -99.76%-40.87%-35.07% Which has more risk and volatility, BDTX or RPTX? Black Diamond Therapeutics has a beta of 2.51, suggesting that its stock price is 151% more volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Does the media favor BDTX or RPTX? In the previous week, Black Diamond Therapeutics had 1 more articles in the media than Repare Therapeutics. MarketBeat recorded 1 mentions for Black Diamond Therapeutics and 0 mentions for Repare Therapeutics. Black Diamond Therapeutics' average media sentiment score of 1.92 beat Repare Therapeutics' score of -0.20 indicating that Black Diamond Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Black Diamond Therapeutics Very Positive Repare Therapeutics Neutral Does the MarketBeat Community prefer BDTX or RPTX? Black Diamond Therapeutics received 10 more outperform votes than Repare Therapeutics when rated by MarketBeat users. Likewise, 69.86% of users gave Black Diamond Therapeutics an outperform vote while only 65.08% of users gave Repare Therapeutics an outperform vote. CompanyUnderperformOutperformBlack Diamond TherapeuticsOutperform Votes5169.86% Underperform Votes2230.14% Repare TherapeuticsOutperform Votes4165.08% Underperform Votes2234.92% Do insiders and institutionals have more ownership in BDTX or RPTX? 95.5% of Black Diamond Therapeutics shares are held by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are held by institutional investors. 8.9% of Black Diamond Therapeutics shares are held by company insiders. Comparatively, 21.6% of Repare Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher valuation and earnings, BDTX or RPTX? Black Diamond Therapeutics has higher earnings, but lower revenue than Repare Therapeutics. Black Diamond Therapeutics is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlack Diamond TherapeuticsN/AN/A-$82.44M-$1.33-1.83Repare Therapeutics$51.13M2.36-$93.80M-$2.00-1.42 SummaryBlack Diamond Therapeutics beats Repare Therapeutics on 11 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$122.43M$6.48B$5.07B$8.89BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-1.424.4283.5712.93Price / Sales2.36375.031,220.3088.33Price / CashN/A52.5939.4636.25Price / Book0.6910.126.936.25Net Income-$93.80M$153.61M$119.12M$225.93M7 Day Performance-12.62%-2.00%-1.83%-1.32%1 Month Performance-21.11%-7.47%-3.64%0.60%1 Year Performance-40.34%31.80%31.64%26.23% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics2.672 of 5 stars$2.84-1.4%$10.00+252.1%-44.7%$122.43M$51.13M-1.42180BDTXBlack Diamond Therapeutics2.8436 of 5 stars$2.43-4.7%$15.50+537.9%+8.0%$144.29MN/A0.0090Positive NewsMREOMereo BioPharma Group2.9665 of 5 stars$3.58+2.6%$7.50+109.5%+63.5%$489.50M$10M0.0040Analyst RevisionNews CoverageARCTArcturus Therapeutics2.0686 of 5 stars$16.17-10.5%$71.40+341.6%-33.7%$489.20M$169.93M-7.28180ALMSAlumisN/A$9.64-6.9%$26.83+178.4%N/A$488.75MN/A0.00N/AAnalyst RevisionHigh Trading VolumeYMABY-mAbs Therapeutics3.3273 of 5 stars$10.54-2.9%$21.38+102.8%+100.8%$486.41M$84.82M0.00150Analyst ForecastZVRAZevra Therapeutics3.4632 of 5 stars$8.97flat$21.00+134.1%+100.2%$478.78M$27.46M-4.5565Analyst ForecastAnalyst RevisionESPREsperion Therapeutics3.9536 of 5 stars$2.41flat$8.17+238.9%+97.5%$474.86M$116.33M-3.77240Analyst ForecastRGNXREGENXBIO4.4242 of 5 stars$9.63+0.7%$35.64+270.1%-51.9%$473.65M$90.24M-1.91344Analyst ForecastAnalyst RevisionSLRNAcelyrin3.3895 of 5 stars$4.43-6.1%$11.50+159.6%-50.2%$473.54MN/A-1.80135Analyst RevisionPositive NewsMGTXMeiraGTx4.3185 of 5 stars$5.82-2.7%$23.50+303.8%+2.8%$467.36M$14.02M0.00300Analyst Forecast Related Companies and Tools Related Companies Black Diamond Therapeutics Alternatives Mereo BioPharma Group Alternatives Arcturus Therapeutics Alternatives Alumis Alternatives Y-mAbs Therapeutics Alternatives Zevra Therapeutics Alternatives Esperion Therapeutics Alternatives REGENXBIO Alternatives Acelyrin Alternatives MeiraGTx Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RPTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPTX Stock Alerts